| DrRom116 vs Law | 10–12 | 45.45% |
| DrRom116 vs King | 11–8 | 57.89% |
| DrRom116 vs Eddy | 11–8 | 57.89% |
| DrRom116 vs Dragunov | 9–6 | 60.00% |
| DrRom116 vs Jun | 8–5 | 61.54% |
| DrRom116 vs Anna | 9–4 | 69.23% |
| DrRom116 vs Nina | 7–5 | 58.33% |
| DrRom116 vs Steve | 11–0 | 100.00% |
| DrRom116 vs Kuma | 4–5 | 44.44% |
| DrRom116 vs Hwoarang | 5–3 | 62.50% |
| DrRom116 vs Azucena | 5–3 | 62.50% |
| DrRom116 vs Armor King | 6–2 | 75.00% |
| DrRom116 vs Jin | 5–2 | 71.43% |
| DrRom116 vs Bryan | 5–2 | 71.43% |
| DrRom116 vs Kazuya | 3–4 | 42.86% |
| DrRom116 vs Raven | 6–1 | 85.71% |
| DrRom116 vs Xiaoyu | 6–0 | 100.00% |
| DrRom116 vs Devil Jin | 4–2 | 66.67% |
| DrRom116 vs Lili | 4–2 | 66.67% |
| DrRom116 vs Shaheen | 6–0 | 100.00% |
| DrRom116 vs Reina | 2–4 | 33.33% |
| DrRom116 vs Victor | 2–4 | 33.33% |
| DrRom116 vs Jack-8 | 4–1 | 80.00% |
| DrRom116 vs Lars | 4–1 | 80.00% |
| DrRom116 vs Alisa | 1–4 | 20.00% |
| DrRom116 vs Lee | 2–3 | 40.00% |
| DrRom116 vs Asuka | 4–0 | 100.00% |
| DrRom116 vs Feng | 4–0 | 100.00% |
| DrRom116 vs Leroy | 1–3 | 25.00% |
| DrRom116 vs Heihachi | 4–0 | 100.00% |
| DrRom116 vs Panda | 1–2 | 33.33% |
| DrRom116 vs Clive | 0–3 | 0.00% |
| DrRom116 vs Paul | 1–1 | 50.00% |
| DrRom116 vs Yoshimitsu | 0–2 | 0.00% |
| DrRom116 vs Leo | 2–0 | 100.00% |
| DrRom116 vs Lidia | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.